Population pharmacokinetic analysis of tacrolimus in Chinese myasthenia gravis patients

The importance of tacrolimus in the treatment of myasthenia gravis (MG) as a substitute for corticosteroid-dependent immunosuppressive therapy is increasing. Thus far, however, no population pharmacokinetic (PopPK) analysis of tacrolimus in treating MG patients has been published. This article aimed...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Acta Pharmacol Sin
Main Authors: Chen, Yu-si, Liu, Zi-qi, Chen, Rong, Wang, Lei, Huang, Ling, Zhu, Xiao, Zhou, Tian-yan, Lu, Wei, Ma, Ping
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2017
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5547552/
https://ncbi.nlm.nih.gov/pubmed/28552913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2016.174
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki